Annovis Bio Inc
ANVS
Market Cap$29.81M
Close$
$0.86
43.6% downside
Current Fair Value
43.6% downsideOvervalued by 43.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $29.81 Million |
|---|---|
| Enterprise Value | $19.26 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-2018.5 |
| Beta | 1.45 |
| Outstanding Shares | 13,794,519 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | 0 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Annovis Bio Inc
CEO: Maria Maccecchini